Cerner's FetaLink+ mobile fetal monitoring app has received clearance from the US Food and Drug Administration.
The app is currently available for iPhones and iPads interfaces with Cerner's PowerChart Touch. It allows physicians to remotely access maternal and fetal data of patients in the clinic.
The app displays the relationship of fetal and maternal waveforms and enables physicians to easily analyze changes in waveform patterns over time and take the necessary action if needed.
"Clinicians can quickly view annotations on the fetal strip. The annotation summary offers clinicians a quick way to review a chronological order of vital signs and annotation entries. The summary also serves as a navigation tool for viewing a historical waveform at the correlating time of entry," said a statement issued by Cerner.